683 Capital Management LLC Invests $713,000 in Myomo, Inc. (NYSEAMERICAN:MYO)

683 Capital Management LLC bought a new position in shares of Myomo, Inc. (NYSEAMERICAN:MYO - Free Report) during the fourth quarter, according to the company in its most recent 13F filing with the Securities & Exchange Commission. The firm bought 110,760 shares of the company's stock, valued at approximately $713,000. 683 Capital Management LLC owned about 0.37% of Myomo at the end of the most recent quarter.

Other institutional investors also recently modified their holdings of the company. Manatuck Hill Partners LLC acquired a new stake in Myomo during the 4th quarter worth $1,582,000. Jane Street Group LLC raised its position in shares of Myomo by 447.2% during the fourth quarter. Jane Street Group LLC now owns 88,320 shares of the company's stock worth $569,000 after purchasing an additional 72,180 shares during the period. Schonfeld Strategic Advisors LLC bought a new position in shares of Myomo during the 4th quarter valued at about $95,000. Northern Trust Corp grew its position in shares of Myomo by 17.6% in the 4th quarter. Northern Trust Corp now owns 49,587 shares of the company's stock valued at $319,000 after purchasing an additional 7,413 shares during the period. Finally, Dauntless Investment Group LLC bought a new stake in Myomo during the 4th quarter worth approximately $1,070,000. 44.99% of the stock is currently owned by institutional investors and hedge funds.

Myomo Price Performance

Shares of MYO traded up $0.03 during trading hours on Wednesday, reaching $4.80. The stock had a trading volume of 113,505 shares, compared to its average volume of 345,147. Myomo, Inc. has a 12 month low of $2.76 and a 12 month high of $7.17. The company has a market cap of $145.05 million, a PE ratio of -20.85 and a beta of 1.68. The stock has a 50-day moving average price of $4.85.

Wall Street Analyst Weigh In

Several equities research analysts recently commented on MYO shares. Ascendiant Capital Markets boosted their price objective on shares of Myomo from $9.00 to $11.00 and gave the company a "buy" rating in a research report on Monday, March 17th. Craig Hallum lifted their target price on Myomo from $9.00 to $11.00 and gave the company a "buy" rating in a research report on Tuesday, March 11th. Alliance Global Partners reaffirmed a "buy" rating on shares of Myomo in a research note on Tuesday, March 11th. Finally, HC Wainwright increased their target price on shares of Myomo from $7.50 to $9.50 and gave the stock a "buy" rating in a report on Wednesday, March 12th. Five analysts have rated the stock with a buy rating, Based on data from MarketBeat.com, the stock presently has a consensus rating of "Buy" and an average target price of $9.75.

Insider Buying and Selling at Myomo

In related news, Director Thomas F. Kirk acquired 7,400 shares of the business's stock in a transaction dated Thursday, March 13th. The shares were bought at an average price of $5.00 per share, with a total value of $37,000.00. Following the transaction, the director now directly owns 255,933 shares of the company's stock, valued at $1,279,665. This trade represents a 2.98 % increase in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, insider Harry Kovelman sold 30,000 shares of the company's stock in a transaction on Wednesday, March 12th. The stock was sold at an average price of $5.50, for a total transaction of $165,000.00. Following the transaction, the insider now owns 97,973 shares in the company, valued at approximately $538,851.50. The trade was a 23.44 % decrease in their position. The disclosure for this sale can be found here. Corporate insiders own 4.54% of the company's stock.

Myomo Profile

Myomo, Inc, a wearable medical robotics company, designs, develops, and produces myoelectric orthotics for people with neuromuscular disorders in the United States, China, Germany, and internationally. The company offers MyoPro, a myoelectric-controlled upper limb brace or orthosis product used for supporting a patient's weak or paralyzed arm to enable and improve functional activities of daily living.